Literature DB >> 12739790

Binge use of methamphetamine among HIV-positive men who have sex with men: pilot data and HIV prevention implications.

Shirley J Semple1, Thomas L Patterson, Igor Grant.   

Abstract

This study compared the social and behavioral characteristics of binge users and nonbinge users of methamphetamine (meth) in a sample of 90 HIV-positive men who have sex with men. Forty-one participants (46%) self-identified as a binge user. Meth binges ranged from 2 to 33 days (mean = 5.6), and average consumption was 3.1 grams. Binge users were significantly more likely than nonbinge users to be ethnic minority and to have lower education. The two groups did not differ in terms of the total amount of meth used in the past 30 days; however, binge users reported significantly more social difficulties, more mental and physical health problems, and more sexual risk behaviors as compared with nonbinge users. The findings are discussed in relation to drug treatment approaches and the development of behavioral interventions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739790     DOI: 10.1521/aeap.15.3.133.23835

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  30 in total

Review 1.  A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine.

Authors:  Radha Rajasingham; Matthew J Mimiaga; Jaclyn M White; Megan M Pinkston; Rachel P Baden; Jennifer A Mitty
Journal:  AIDS Patient Care STDS       Date:  2011-11-09       Impact factor: 5.078

2.  Sexual risk reduction among HIV-positive drug-using men who have sex with men.

Authors:  Thomas L Patterson; Shirley J Semple
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

3.  Visual memory in methamphetamine-dependent individuals: deficient strategic control of encoding and retrieval.

Authors:  Erin E Morgan; Steven P Woods; Amelia J Poquette; Ofilio Vigil; Robert K Heaton; Igor Grant
Journal:  Aust N Z J Psychiatry       Date:  2012-02       Impact factor: 5.744

Review 4.  Neurocognitive effects of methamphetamine: a critical review and meta-analysis.

Authors:  J Cobb Scott; Steven Paul Woods; Georg E Matt; Rachel A Meyer; Robert K Heaton; J Hampton Atkinson; Igor Grant
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

5.  Binge use and sex and drug use behaviors among HIV(-), heterosexual methamphetamine users in San Diego.

Authors:  W Susan Cheng; Richard S Garfein; Shirley J Semple; Steffanie A Strathdee; James K Zians; Thomas L Patterson
Journal:  Subst Use Misuse       Date:  2010       Impact factor: 2.164

Review 6.  Epidemiology of Injection Drug Use: New Trends and Prominent Issues.

Authors:  Élise Roy; Nelson Arruda; Julie Bruneau; Didier Jutras-Aswad
Journal:  Can J Psychiatry       Date:  2016-02-10       Impact factor: 4.356

7.  Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humans.

Authors:  Matthew G Kirkpatrick; Erik W Gunderson; Frances R Levin; Richard W Foltin; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2011-07-12       Impact factor: 4.530

8.  Drug use among gay and bisexual men at weekend dance parties: the role of intentions and perceptions of peers' behaviors.

Authors:  Rajeev Ramchand; Michael P Fisher; Beth Ann Griffin; Kirsten Becker; Martin Y Iguchi
Journal:  AIDS Behav       Date:  2013-05

9.  Testing the Efficacy of Combined Motivational Interviewing and Cognitive Behavioral Skills Training to Reduce Methamphetamine Use and Improve HIV Medication Adherence Among HIV-Positive Gay and Bisexual Men.

Authors:  Jeffrey T Parsons; Steven A John; Brett M Millar; Tyrel J Starks
Journal:  AIDS Behav       Date:  2018-08

10.  Positive affect and processes of recovery among treatment-seeking methamphetamine users.

Authors:  Adam W Carrico; William J Woods; Michael D Siever; Michael V Discepola; Samantha E Dilworth; Torsten B Neilands; Nicole Miller; Judith Tedlie Moskowitz
Journal:  Drug Alcohol Depend       Date:  2013-05-16       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.